RareSearch logo

The Wistar Institute Proteomics Facility

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Winston Labadie profile

Winston Labadie

πŸ‡ΉπŸ‡· Turkey

6.2

    Reviewed:

  • - Clinical Protocol Design
  • - 10 weeks January - March 2024
  • - Pharmaceutical Company

Inconsistent quality of deliverables, frequent revisions needed.

The protocol design process required multiple revisions due to inconsistencies in the deliverables. Although the team was responsive to feedback, the back-and-forth extended the timeline beyond what was originally agreed upon.

Mr. Javier Lebsack profile

Mr. Javier Lebsack

πŸ‡―πŸ‡΅ Japan

9.1

    Reviewed:

  • - Clinical Data Management
  • - 6 weeks June - July 2023
  • - CRO

Timely and accurate data management, great collaboration.

The data management services were delivered on time and with great accuracy. Collaboration with the team was smooth, and they were always available to address any concerns or questions we had. We were very satisfied with the outcome.

Allan Wisozk-Kertzmann profile

Allan Wisozk-Kertzmann

πŸ‡ΊπŸ‡Έ United States

8.9

    Reviewed:

  • - Stability Studies
  • - 18 months January 2023 - June 2024
  • - Pharmaceutical Company

Accurate and reliable stability studies, clear reporting.

The stability studies were conducted with precision, and the reporting was clear and thorough. The results provided us with the necessary data to proceed with our regulatory submissions confidently.

Dr. Rogelio Kozey profile

Dr. Rogelio Kozey

πŸ‡ΈπŸ‡¦ Saudi Arabia

9.1

    Reviewed:

  • - Pharmacovigilance Services
  • - Ongoing
  • - Pharmaceutical Company

Highly effective pharmacovigilance services, ensured compliance.

The pharmacovigilance services ensured that our post-market surveillance was compliant and effective. The team was proactive in monitoring and reporting, providing us with peace of mind and ensuring patient safety.

Rosie Johnston profile

Rosie Johnston

πŸ‡«πŸ‡· France

6.5

    Reviewed:

  • - Regulatory Submission
  • - 8 weeks May - July 2024
  • - Pharmaceutical Company

Regulatory submission was incomplete, required additional work.

The initial regulatory submission provided was incomplete, requiring additional work to meet the necessary standards. This resulted in unexpected costs and delays. The team corrected the issues, but it should have been right the first time.

Kristen Luettgen profile

Kristen Luettgen

πŸ‡·πŸ‡Ί Russia

9.1

    Reviewed:

  • - HTA Submission
  • - 8 weeks February - March 2024
  • - Biotech Company

Comprehensive and well-executed HTA submission.

The HTA submission was comprehensive and well-executed. The team managed the complexities of the submission process expertly, ensuring that all necessary data was included and well-presented.

Dean Hahn PhD profile

Dean Hahn PhD

πŸ‡ͺπŸ‡Έ Spain

8.9

    Reviewed:

  • - Regulatory Submission
  • - 6 weeks February 2023
  • - Biotech Startup

Professional and knowledgeable, seamless regulatory submission process.

Our regulatory submission was handled with great care and expertise. The process was seamless, and their knowledge of the regulatory landscape was impressive. The team's support was invaluable, and I would not hesitate to use their services again.

Mr. Laurence Green profile

Mr. Laurence Green

πŸ‡¬πŸ‡§ United Kingdom

9.3

    Reviewed:

  • - Project Management
  • - 10 weeks July - September 2023
  • - Biotech Company

Seamless project management, results exceeded expectations.

Project management was seamless, and the team exceeded our expectations. They handled all aspects of the project with professionalism and efficiency, keeping us informed every step of the way.